21-(ACETYLOXY)-6,9-DIFLUORO-11-HYDROXY-16-METHYL-17-((1-OXOPENTYL)OXY)PREGNA-1,4-DIENE-3,20-DIONE, (6.ALPHA.,11.BETA.,16.ALPHA.)-
UNII AHV8B1474L
Substance Identification & Data
This profile provides standardized clinical and technical data for 21-(acetyloxy)-6,9-difluoro-11-hydroxy-16-methyl-17-((1-oxopentyl)oxy)pregna-1,4-diene-3,20-dione, (6.alpha.,11.beta.,16.alpha.)-, uniquely identified by the FDA Unique Ingredient Identifier (UNII) AHV8B1474L.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 79861-40-8 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C29H38F2O7 SGBZKCKAGMDBKU-DXRJZBQRSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 21-(acetyloxy)-6,9-difluoro-11-hydroxy-16-methyl-17-((1-oxopentyl)oxy)pregna-1,4-diene-3,20-dione, (6.alpha.,11.beta.,16.alpha.)-. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.